文献速递系统性红斑狼疮

狼疮肾炎肾外疾病模式:临床与血清学活动增加肾脏复发及损伤累积风险

Extra-renal disease patterns in lupus nephritis: clinical and serological activity confers increased risk of renal flares and damage accrual.
PubMed 文献 · Rheumatology (Oxford) · 2026-10-27

多中心回顾性队列纳入168例活检证实的狼疮肾炎且达肾脏缓解患者,中位随访4.0年。肾外活动常见(92.3%至少一次),临床显著肾外复发37.5%。非肾SLEDAI-2K评分升高独立关联后续肾脏复发(aHR 1.18,95%CI 1.07-1.30)和损伤累积(aHR 1.23,95%CI 1.13-1.35),BILAG-A肾外复发与损伤累积强关联(aHR 10.56,95%CI 4.63-24.06)。潜类别分析识别三种肾外活动模式,仅混合血清学-临床活动表型独立关联肾脏复发(aHR 2.66,95%CI 1.34-5.30)和损伤累积(aHR 2.37,95%CI 1.07-5.25)。

要点

  • 狼疮肾炎肾脏缓解后肾外活动常见,临床显著肾外复发见于37.5%患者。
  • 非肾SLEDAI-2K评分升高独立增加肾脏复发和损伤累积风险。
  • 混合血清学-临床活动表型独立关联肾脏复发和损伤累积。

核心结论

  • 狼疮肾炎肾脏缓解后肾外活动常见,抗dsDNA阳性是关联不良结局的主要因素,合并临床肾外活动可能进一步增加血清学活动患者的风险。

研究设计与样本

  • 多中心回顾性队列研究纳入168例活检证实的狼疮肾炎且达肾脏缓解患者,采用潜类别分析识别肾外活动模式,Cox比例风险模型评估关联。

主要发现

  • 中位随访4.0年,92.3%患者至少一次出现肾外活动,血清学活动最常见,其次为皮肤黏膜和肌肉骨骼受累。
  • 临床显著肾外复发发生于37.5%患者。
  • 非肾SLEDAI-2K评分升高独立关联后续肾脏复发(aHR 1.18,95%CI 1.07-1.30)和损伤累积(aHR 1.23,95%CI 1.13-1.35)。
  • BILAG-A肾外复发与损伤累积强关联(aHR 10.56,95%CI 4.63-24.06)。
  • 潜类别分析识别三种肾外活动模式:皮肤黏膜/肌肉骨骼型、混合血清学-临床活动型、以低补体血症为主型;仅混合表型独立关联肾脏复发(aHR 2.66,95%CI 1.34-5.30)和损伤累积(aHR 2.37,95%CI 1.07-5.25)。

关键数值与推荐

  • 非肾SLEDAI-2K评分每升高1分,后续肾脏复发风险aHR 1.18(95%CI 1.07-1.30),损伤累积风险aHR 1.23(95%CI 1.13-1.35)。
  • BILAG-A肾外复发与损伤累积的aHR 10.56(95%CI 4.63-24.06)。
  • 混合血清学-临床活动表型与肾脏复发的aHR 2.66(95%CI 1.34-5.30),与损伤累积的aHR 2.37(95%CI 1.07-5.25)。

临床怎么用

  • 狼疮肾炎患者达肾脏缓解后应持续监测肾外活动,尤其血清学活动(抗dsDNA阳性、低补体血症)和临床肾外表现。
  • 非肾SLEDAI-2K评分升高或BILAG-A肾外复发提示肾脏复发和损伤累积风险增加,需加强随访。
  • 混合血清学-临床活动表型患者可能需更密切监测和积极管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore patterns of extra-renal disease activity following renal response in lupus nephritis (LN) and evaluate their association with renal flares and organ damage accrual. METHODS: Multicenter retrospective cohort study of patients with biopsy-proven LN who achieved renal response. Latent class analysis (LCA) was applied to identify patterns of extra-renal activity. Associations with adverse outcomes were examined using Cox proportional hazards models. RESULTS: A total of 168 patients were included. Over a median follow-up of 4.0 years, 92.3% of patients exhibited extra-renal activity at least once. Serological activity (anti-dsDNA positivity and/or hypocomplementemia) was the most frequent active domain, followed by mucocutaneous and musculoskeletal involvement. Clinically significant extra-renal flares occurred in 37.5% of patients. Higher non-renal SLEDAI-2K scores were independently associated with increased risk of subsequent renal flares (aHR 1.18, 95% CI 1.07-1.30) and damage accrual (aHR 1.23, 95% CI 1.13-1.35), while BILAG-A extra-renal flares were strongly associated with damage accrual (aHR 10.56, 95% CI 4.63-24.06). LCA identified three classes of extra-renal activity: (1) mucocutaneous/musculoskeletal, (2) combined serological-clinical activity, and (3) predominant hypocomplementemia. Only the combined phenotype was independently associated with renal flares (aHR 2.66, 95% CI 1.34-5.30) and damage accrual (aHR 2.37, 95% CI 1.07-5.25). In exploratory analyses stratified by anti-dsDNA status, clinical extra-renal activity was associated with adverse outcomes among anti-dsDNA positive visits. CONCLUSIONS: Extra-renal activity in LN following renal response is common. Anti-dsDNA positivity is the main factor associated with adverse outcomes, while concomitant clinical extra-renal activity may further increase risk among serologically active patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Drougkas, Katechis, Nikoloudaki, et al. Extra-renal disease patterns in lupus nephritis: clinical and serological activity confers increased risk of renal flares and damage accrual. Rheumatology (Oxford). 2026. PMID: 42937124. doi:10.1093/rheumatology/keag604

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。